Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Lembo AJ, Johanson JF, Parkman HP, Rao SS, Miner PB Jr, Ueno R.

Dig Dis Sci. 2011 Sep;56(9):2639-45. doi: 10.1007/s10620-011-1801-0. Epub 2011 Jul 19.

PMID:
21769655
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.

Johanson JF, Morton D, Geenen J, Ueno R.

Am J Gastroenterol. 2008 Jan;103(1):170-7. Epub 2007 Oct 4.

PMID:
17916109
[PubMed - indexed for MEDLINE]
4.

Lubiprostone: chloride channel activator for chronic constipation.

Rivkin A, Chagan L.

Clin Ther. 2006 Dec;28(12):2008-21. Review.

PMID:
17296458
[PubMed - indexed for MEDLINE]
5.

Efficacy and safety of lubiprostone in patients with chronic constipation.

Barish CF, Drossman D, Johanson JF, Ueno R.

Dig Dis Sci. 2010 Apr;55(4):1090-7. doi: 10.1007/s10620-009-1068-x. Epub 2009 Dec 11.

PMID:
20012484
[PubMed - indexed for MEDLINE]
6.

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation.

Chey WD, Drossman DA, Johanson JF, Scott C, Panas RM, Ueno R.

Aliment Pharmacol Ther. 2012 Mar;35(5):587-99. doi: 10.1111/j.1365-2036.2011.04983.x. Epub 2012 Jan 18.

PMID:
22251419
[PubMed - indexed for MEDLINE]
7.

Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation.

Saad R, Chey WD.

Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):497-508. doi: 10.1586/17474124.2.4.497.

PMID:
19072397
[PubMed - indexed for MEDLINE]
8.

Lubiprostone.

McKeage K, Plosker GL, Siddiqui MA.

Drugs. 2006;66(6):873-9.

PMID:
16706562
[PubMed - indexed for MEDLINE]
9.

Lubiprostone: a chloride channel activator for treatment of chronic constipation.

Ambizas EM, Ginzburg R.

Ann Pharmacother. 2007 Jun;41(6):957-64. Epub 2007 May 22. Review.

PMID:
17519292
[PubMed - indexed for MEDLINE]
10.

Lubiprostone: RU 0211, SPI 0211.

[No authors listed]

Drugs R D. 2005;6(4):245-8. Review.

PMID:
15991886
[PubMed - indexed for MEDLINE]
11.

Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.

Chamberlain SM, Rao SS.

Expert Opin Drug Saf. 2012 Sep;11(5):841-50. doi: 10.1517/14740338.2012.708732. Epub 2012 Jul 27. Review.

PMID:
22834474
[PubMed - indexed for MEDLINE]
12.

Lubiprostone for constipation and irritable bowel syndrome with constipation.

Tuteja AK, Rao SS.

Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):727-33. doi: 10.1586/17474124.2.6.727.

PMID:
19090733
[PubMed - indexed for MEDLINE]
13.

Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.

Lacy BE, Chey WD.

Expert Opin Pharmacother. 2009 Jan;10(1):143-52. doi: 10.1517/14656560802631319 . Review.

PMID:
19236188
[PubMed - indexed for MEDLINE]
14.

Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.

Owen RT.

Drugs Today (Barc). 2008 Sep;44(9):645-52. doi: 10.1358/dot.2008.44.9.1269852. Review.

PMID:
19137119
[PubMed - indexed for MEDLINE]
15.

Lubiprostone: a chloride channel activator.

Lacy BE, Levy LC.

J Clin Gastroenterol. 2007 Apr;41(4):345-51. Review.

PMID:
17413599
[PubMed - indexed for MEDLINE]
16.

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R.

Aliment Pharmacol Ther. 2008 Apr;27(8):685-96. doi: 10.1111/j.1365-2036.2008.03629.x. Epub 2008 Jan 28.

PMID:
18248656
[PubMed - indexed for MEDLINE]
17.

Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.

Ginzburg R, Ambizas EM.

Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1091-7. doi: 10.1517/17425255.4.8.1091 . Review.

PMID:
18680443
[PubMed - indexed for MEDLINE]
18.

Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation.

Crowell MD, Harris LA, DiBaise JK, Olden KW.

Curr Opin Investig Drugs. 2007 Jan;8(1):66-70. Review.

PMID:
17263187
[PubMed - indexed for MEDLINE]
19.

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):329-41. doi: 10.1111/j.1365-2036.2008.03881.x. Epub 2008 Nov 4.

PMID:
19006537
[PubMed - indexed for MEDLINE]
20.

Lubiprostone: in constipation-predominant irritable bowel syndrome.

Carter NJ, Scott LJ.

Drugs. 2009 Jun 18;69(9):1229-37. doi: 10.2165/00003495-200969090-00007. Review.

PMID:
19537839
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk